COLOMBIAN MEDICINAL GRADE CANNABIS FLOWER NOW LEGAL TO EXPORT

  • COLOMBIAN PRESIDENT SIGNS A NEW DECREE FOR THE CANNABIS INDUSTRY 
  • Companies are now permitted to export flower as a finished product 
  • Plena’s LATAM strategy continues to gain momentum with first mover advantage for export of premium cannabis flower under new decree

 

Plena Global Holdings Inc. (“Plena Global” or the “Company”) is pleased to announce that on July 23rd, 2021, the Colombian President Iván Duque Marquez signed a new master decree for the cannabis industry.  

The new decree replaces the existing decree 613 (2017) and establishes a legal framework for the export of cannabis flower for medical and scientific purposes. The decree also regulates the domestic commercialization of CBD in a range of OTC wellness products and encourages the development of a domestic CBD infused food and beverage market. There are also important changes on the use of cannabinoids for veterinary use opening yet another lucrative product category.  

 The changes follow months of successful lobbying by members of the Asocolcanna – the Colombian Cannabis Association. 

 According to data of the German Federal Institute for Drugs and Medical Devices (BfArM) in 2020 Germany imported over 6 tons of dry medical cannabis flower for pharmacy dispensing. Sales of dry medical cannabis flowers are legal in many countries, including Australia, New Zealand, Canada, United Kingdom, Portugal, Czech Republic, Italy, Luxembourg, Malta, Poland.  

As a result of the enactment of the new legislation, as one of the leading Colombian cultivators at scale Plena is now uniquely positioned with first-mover advantage to access certain global markets with premium medical cannabis flower due to early investment in high-tech Richel Greenhouse and its Control Union CUMCS-GACP certification, one of the only Colombian cultivators to achieve this certification. 

 Plena is currently taking pre-orders from authorized global parties with respect to premium medical cannabis flower and encourages all interested parties to contact the Plena sales team at the contacts below. 

 

Contact: 

Mauricio Krausz: CEO Plena Global Holding Inc. – mkrausz@plena.global 

 

About Plena Global 

Plena Global is a global B2B cannabis production company, headquartered in Victoria, British Columbia, with a focus on supplying medical-grade cannabis products to licensed producers, pharmaceutical companies, manufacturers, and distributors worldwide. With landholdings strategically located in South America, Plena Global is able to scale cultivation and production operations in optimal growing environments.    

 Through consistent presence, education, and country-specific expertise, Plena Global has emerged as the global leader in ‘people first’ medical cannabis. As a company, its commitment to this mission and the vision that equity and patient rights and needs are not mutually exclusive, have enabled Plena Global to evolve and grow at scale.  

 

View on instagram: https://www.instagram.com/p/CRrj0LeszCF/

 

Like this article?

Share on facebook
Share on Facebook
Share on twitter
Share on Twitter
Share on linkedin
Share on LinkedIn
Share on pinterest
Share on Pinterest

Leave a comment

Contact Us

Learn more about the medical-grade cannabis products we produce